It could be a bug bite. Or a harmless fatty lump. But it might be a mast cell tumor. In this episode of the VetFolio Voice podcast, we delve into mast cell tumors in dogs, including the unpredictable nature of these tumors, nuances around interpretation of cytology and histopathology reports, cytologic grading accuracy, and options for therapy including surgery, chemo, radiation and Stelfonta, an injectable mast cell tumor treatment for dogs. You’ll learn about staging considerations and the role of newer prognostic panels as well as strategies for client communication about mast cell disease.
All content for VetFolio Voice is the property of Powered by the NAVC and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
It could be a bug bite. Or a harmless fatty lump. But it might be a mast cell tumor. In this episode of the VetFolio Voice podcast, we delve into mast cell tumors in dogs, including the unpredictable nature of these tumors, nuances around interpretation of cytology and histopathology reports, cytologic grading accuracy, and options for therapy including surgery, chemo, radiation and Stelfonta, an injectable mast cell tumor treatment for dogs. You’ll learn about staging considerations and the role of newer prognostic panels as well as strategies for client communication about mast cell disease.
Phosphorus control is crucial in managing canine and feline chronic kidney disease (CKD), particularly in cats. Because the disease is progressive and incurable, monitoring a cat with CKD is vitally important. With early detection and management, you can significantly extend your patient's lifespan and maintain a good quality of life. In this VetFolio Voice podcast episode, we delve into the monitoring of CKD in cats—including assessing Blood Urea Nitrogen (BUN), creatinine, Symmetric Dimethylarginine (SDMA), proteinuria and blood pressure—and how phosphorus can get lost in the shuffle, especially if it is within the normal reference range. Learn why it is important to continue to actively monitor and manage phosphorus since it is a disease accelerant even before the concentration leaves the normal reference range. We discuss the pathophysiology behind hyperphosphatemia, how to effectively monitor phosphorous levels in order to be able to intervene early, options for managing hyperphosphatemia and updates to the IRIS guidelines.
VetFolio Voice
It could be a bug bite. Or a harmless fatty lump. But it might be a mast cell tumor. In this episode of the VetFolio Voice podcast, we delve into mast cell tumors in dogs, including the unpredictable nature of these tumors, nuances around interpretation of cytology and histopathology reports, cytologic grading accuracy, and options for therapy including surgery, chemo, radiation and Stelfonta, an injectable mast cell tumor treatment for dogs. You’ll learn about staging considerations and the role of newer prognostic panels as well as strategies for client communication about mast cell disease.